188 related articles for article (PubMed ID: 19920921)
1. Alitretinoin--its use in intractable hand eczema and other potential indications.
Petersen B; Jemec GB
Drug Des Devel Ther; 2009 Sep; 3():51-7. PubMed ID: 19920921
[TBL] [Abstract][Full Text] [Related]
2. Alitretinoin: a comprehensive review.
Cheng C; Michaels J; Scheinfeld N
Expert Opin Investig Drugs; 2008 Mar; 17(3):437-43. PubMed ID: 18321241
[TBL] [Abstract][Full Text] [Related]
3. The Endogenous Dual Retinoid Receptor Agonist Alitretinoin Exhibits Immunoregulatory Functions on Antigen-Presenting Cells.
Kislat A; Olah P; Kuchner M; Gerber PA; Schrader J; Meller S; Homey B
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298605
[TBL] [Abstract][Full Text] [Related]
4. Expression of retinoid receptors in hand eczema.
Nada HR; Rashed LA; Elantably DMM; El Sharkawy DA
Int J Dermatol; 2020 May; 59(5):576-581. PubMed ID: 32129477
[TBL] [Abstract][Full Text] [Related]
5. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
6. Alitretinoin: in severe chronic hand eczema.
Garnock-Jones KP; Perry CM
Drugs; 2009 Aug; 69(12):1625-34. PubMed ID: 19678713
[TBL] [Abstract][Full Text] [Related]
7. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
Molin S; Ruzicka T
Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
[TBL] [Abstract][Full Text] [Related]
8. Update on the use of alitretinoin in treating chronic hand eczema.
Ghasri P; Scheinfeld N
Clin Cosmet Investig Dermatol; 2010 Apr; 3():59-65. PubMed ID: 21437060
[TBL] [Abstract][Full Text] [Related]
9. Alitretinoin: An Update of Real-World Evidence in The Management of Chronic Hand Dermatitis.
Gooderham MJ
Skin Therapy Lett; 2018 Jul; 23(4):1-4. PubMed ID: 30086182
[TBL] [Abstract][Full Text] [Related]
10. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
11. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
12. Alitretinoin in Dermatology-An Update.
Bubna AK
Indian J Dermatol; 2015; 60(5):520. PubMed ID: 26538721
[TBL] [Abstract][Full Text] [Related]
13. Safe and effective use of alitretinoin in children with recalcitrant hand eczema and other dermatoses - a retrospective analysis.
Luchsinger I; Vogler T; Schwieger-Briel A; Knöpfel N; Wälchli R; Weibel L; Theiler M
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1037-1042. PubMed ID: 31742759
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
15. Alitretinoin for the treatment of severe chronic eczema of the hands.
Napolitano M; Potestio L; De Lucia M; Nocerino M; Fabbrocini G; Patruno C
Expert Opin Pharmacother; 2022 Feb; 23(2):159-167. PubMed ID: 34789049
[TBL] [Abstract][Full Text] [Related]
16. [Retinoids: mechanisms of action].
Berbis P
Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985
[TBL] [Abstract][Full Text] [Related]
17. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
18. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Morris M; Schifano L; Fong R; Graff O
J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
20. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
